STOCK TITAN

21Shares Solana ETF (TSOL) switches from CF Benchmarks to FTSE for NAV data

(Neutral)
(Neutral)
Form Type
424B3

Rhea-AI Filing Summary

21Shares Solana ETF (TSOL) filed a prospectus supplement dated July 7, 2026 to include a Form 8-K reporting a change in its pricing benchmark arrangements. The Sponsor provided notice on June 30, 2026 to terminate the licensing agreement with CF Benchmarks effective August 31, 2026.

The supplement states the Sponsor intends to enter into a licensing agreement with FTSE International Limited on or about August 24, 2026 to obtain a non-exclusive, perpetual, worldwide license to FTSE index data for use by the Sponsor, the Trust, and their affiliates in valuing the Trust and calculating net asset value.

Positive

  • None.

Negative

  • None.

Insights

Trust is switching benchmark providers from CF Benchmarks to FTSE with specific effective dates.

The filing states the Sponsor provided notice to terminate the Pricing Benchmark Licensing Agreement with CF Benchmarks effective August 31, 2026, and expects to enter a license with FTSE on or about August 24, 2026. The Pricing Benchmark was used to value the Trust’s shares and calculate net asset value.

The change is described as a Sponsor-led transition; cash-flow treatment and operational transition mechanics are not described in the excerpt. Subsequent filings or disclosures may confirm the exact licensing terms and operational cutover details.

Benchmark swap is administrative but impacts NAV data sourcing.

The Pricing Benchmark Licensing Agreement provided a license to use the CME CF Solana-Dollar Reference Rate for daily valuation and NAV calculation. FTSE is identified as the incoming provider and is described as experienced in calculating digital asset indices.

The filing preserves that both CF Benchmarks and FTSE are unaffiliated with the Sponsor. Timing stated: notice June 30, 2026; CF Benchmarks termination effective August 31, 2026; FTSE license expected on or about August 24, 2026.

Form 8-K date June 30, 2026 Date of earliest event reported
Termination effective August 31, 2026 CF Benchmarks Pricing Benchmark Licensing Agreement termination effective date
FTSE license expected August 24, 2026 Sponsor intends to enter into FTSE licensing agreement on or about this date
Commission File Number 001-42904 Registrant commission file number listed in the Form 8-K
Pricing Benchmark Licensing Agreement regulatory
"termination of the licensing agreement (the "Pricing Benchmark Licensing Agreement")"
CME CF Solana-Dollar Reference Rate - New York Variant financial
"use of the CME CF Solana-Dollar Reference Rate - New York Variant (the "Pricing Benchmark")"
net asset value financial
"used to value the Trust’s shares on a daily basis and to calculate the Trust’s net asset value"
Net asset value is the total value of an investment fund's assets minus any liabilities, divided by the number of shares or units outstanding. It represents the per-share worth of the fund, similar to how the value of a house is determined by its total worth after debts are subtracted. Investors use it to gauge the true value of their holdings and to compare different investment options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What change did 21Shares Solana ETF (TSOL) disclose in the July 7, 2026 supplement?

The Trust disclosed termination of its Pricing Benchmark Licensing Agreement with CF Benchmarks, effective August 31, 2026. The Sponsor also stated an intention to enter a license with FTSE on or about August 24, 2026 for FTSE index data.

Which benchmark will TSOL stop using and when will termination take effect?

TSOL will stop using the CME CF Solana-Dollar Reference Rate - New York Variant under the Pricing Benchmark Licensing Agreement, with termination effective August 31, 2026, as stated in the filing.

Which new index provider does the Sponsor intend to use for TSOL?

The Sponsor intends to enter into a licensing agreement with FTSE International Limited on or about August 24, 2026 to obtain FTSE index data for the Trust’s valuation and NAV calculations.

Are CF Benchmarks and FTSE affiliated with the Sponsor?

The filing states CF Benchmarks is unaffiliated with the Sponsor and that FTSE is also unaffiliated with the Sponsor. Both providers are described as independent of the Sponsor.

What role did the Pricing Benchmark serve for the Trust?

The Pricing Benchmark was used to value the Trust’s shares on a daily basis and to calculate the Trust’s net asset value, per the supplement and Form 8-K text.

Filed pursuant to Rule 424(b)(3)

Registration No. 333-280557

 

21SHARES SOLANA ETF

SUPPLEMENT NO. 6 DATED JULY 7, 2026

TO THE PROSPECTUS DATED NOVEMBER 18, 2025

 

This prospectus supplement (this “Supplement”) is part of and should be read in conjunction with the prospectus of 21Shares Solana ETF (the “Trust”), dated November 18, 2025 (the “Prospectus”). Unless otherwise defined herein, capitalized terms used in this Supplement shall have the same meanings as in the Prospectus.

 

The purpose of this Supplement is to include the Trust’s Current Report on Form 8-K filed on July 7, 2026.

 

Current Report on Form 8-K

 

On July 7, 2026, the Trust filed its Current Report on Form 8-K (the “Report”) with the Securities and Exchange Commission. The Report (without exhibits) is attached to this Supplement.

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 30, 2026

 

 

 

21SHARES SOLANA ETF

(Exact name of registrant as specified in its charter)

 

Delaware   001-42904   39-6900299
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

158 W. 27th Street    
New York, New York   10001
(Address of principal executive offices)   (zip code)

 

Registrant’s telephone number, including area code: (646) 370-6016

 

 

 

(Former Name or Former Address, if Changed Since Last Report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Shares of Beneficial Interest of 21Shares Solana ETF   TSOL   Cboe BZX Exchange, Inc.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

Item 1.02 Termination of a Material Definitive Agreement.

 

Benchmark Licensing Agreements

 

On June 30, 2026, 21Shares US LLC (the “Sponsor”) provided notice to CF Benchmarks Ltd. (“CF Benchmarks”) of the termination, effective August 31, 2026, of the licensing agreement (the “Pricing Benchmark Licensing Agreement”) between the Sponsor and CF Benchmarks relating to the use of the CME CF Solana-Dollar Reference Rate - New York Variant (the “Pricing Benchmark”) by the Sponsor, 21Shares Solana ETF (the “Trust”), and their affiliates. Pursuant to the Pricing Benchmark Licensing Agreement, CF Benchmarks provides each of the Sponsor, the Trust, and their affiliates a non-exclusive, non-transferable, non-sub-licensable, perpetual, worldwide license to access, view and use the Pricing Benchmark to develop, create, calculate, settle, maintain or support and market the Trust, with the Trust using the Pricing Benchmark pursuant to a sub-licensing arrangement with the Sponsor. The Pricing Benchmark Licensing Agreement has a one-year initial term and automatically renews for successive one-year periods unless terminated pursuant to its terms. The Pricing Benchmark is calculated and administered by CF Benchmarks and is used to value the Trust’s shares on a daily basis and to calculate the Trust’s net asset value. CF Benchmarks is unaffiliated with the Sponsor. The Sponsor has elected to terminate the Pricing Benchmark Licensing Agreement pursuant to its terms in connection with its broader transition to a new benchmark provider, as further described below.

 

The Sponsor intends to enter into a licensing agreement with FTSE International Limited (“FTSE”) on or about August 24, 2026 whereby FTSE will provide each of the Sponsor, the Trust, and their affiliates a non-exclusive, non-transferable, non-sub-licensable, perpetual, worldwide license to access, view and use FTSE index data to develop, create, calculate, settle, maintain or support and market the Trust. Such license is expected to have a one-year initial term and will automatically be renewed for successive one-year periods, unless terminated pursuant to its terms.

 

FTSE is a company incorporated and registered in England, and its principal offices are located at 10 Paternoster Square, London, EC4M 7LS, United Kingdom. FTSE is experienced in calculating and administering digital asset indices. FTSE is unaffiliated with the Sponsor.

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 7, 2026 21SHARES SOLANA ETF
   
  21Shares US LLC, as Sponsor of 21Shares Solana ETF
   
  By: /s/ Duncan Moir
  Name: Duncan Moir
  Title: President

 

2